BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20240918T151500
DTEND;TZID=Europe/Stockholm:20240918T161500
DTSTAMP:20260422T015523
CREATED:20240829T065531Z
LAST-MODIFIED:20240829T065536Z
UID:172223-1726672500-1726676100@www.scilifelab.se
SUMMARY:[The Svedberg seminar] - Leveraging innate immunity against epidemic and pandemic viruses
DESCRIPTION:Michael GaleProfessorThe University of Washington School of Medicine\, USA \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nBio\n\n\n\nDr. Gale’s research program is focused on understanding the virus-host interactions that regulate innate immunity against virus infection. His group studies SARS-CoV-2\, CoVs\, HIV\, SIV\, hepatitis B virus\, hepatitis C virus\, influenza A virus\, hantaviruses\, West Nile virus\, Zika virus\, Dengue virus\, and other RNA viruses\, aiming to define the processes of virus recognition by the infected cell\, and how viruses control of innate immunity and immune programming to direct infection outcome. A major goal of the Gale laboratory is to define therapeutic targets to enhance immunity and vaccination outcomes against virus infection. Dr. Gale is a Principle Investigator (PI) of UWARN\, one of the NIH Centers for Research on Emerging Infectious Disease (CREID)\, and he also leads the NIH/DAIDS Nonhuman Primate Functional Genomics Core for HIV Vaccine Development. His group conducts functional genomics analyses of virus infection including assessment of preclinical HIV/SIV vaccines being tested in NIH-supported studies. These activities include bioinformatics/computational analyses of infection and vaccine responses and their linkage with mechanisms of action and disease or protection outcomes. Gale lab research is among the top 1% cited worldwide in the field of Microbiology since 2014. Dr. Gale teaches virology\, immunology\, infectious disease biology\, and public health to medical students and graduate students\, and is a member of the editorial board of several biomedical research journals. \n\n\n\nIn October 2024 Dr. Gale will relocate his lab to the University of Minnesota (UM) School of Medicine where he will be the Chair of the Department of Microbiology and Immunology\, and Director of the Institute on Infectious Disease. Contact: mgale@umn.edu \n\n\n\n \n\n\n\nLeveraging innate immunity against epidemic and pandemic viruses\n\n\n\nInnate immune defenses are essential for restricting virus replication and for programming the adaptive immune response against infection. Our studies are focused on defining the innate immune response to emerging viruses.  We have ongoing studies to define pathogen recognition receptor interactions and signaling events triggered by viral pathogen associated molecular patterns (PAMPs) across viral genera that drive innate antiviral immunity and program/enhance the adaptive immune response against infection\, with special focus on neuroinvasive flaviviruses\, SARS-CoV-2\, HIV\, and influenza A virus. We aim to translate our findings to build strategies for antiviral therapy and immune enhancement. This work has defined the RIG-I-like receptors\, including RIG-I\, MDA5\, and LGP2\, as critical factors in the recognition of RNA virus infection and immune protection against disease. We have identified distinct PAMP/RLR interactions that serve to program the outcome of infection and immunity. An overview of our emerging virus research program\, including SARS-CoV-2\, will be presented\, followed by an in-depth presentation of our work to define Zika virus infection\, immunity\, and disease. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nHost: Jan Komorowski jan.komorowski@icm.uu.se
URL:https://www.scilifelab.se/event/the-svedberg-seminar-michael-gale/
LOCATION:BMC Room C8:301\, Husargatan 3\, Uppsala\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/02/Picture1-The-Svedberg.png
END:VEVENT
END:VCALENDAR